Jordan Zwick
Fortuna: 454 820 $ al 30/09/2026
Fortuna: 454 820 $ al 30/09/2026
Mr. Jordan Zwick is a Venture Partner at ARCH Venture Partners LLC, an Independent Director at Palisade Bio, Inc. and an Independent Director at Theratechnologies, Inc. He is on the Board of Directors at Palisade Bio, Inc. and Theratechnologies, Inc. Mr. Zwick was previously employed as a SVP-Corporate Business Development by Amarin Corp.
Plc, a Head-Strategy by Salix Pharmaceuticals Ltd., a Trading Associate by Raymond James & Associates, Inc., and a Chief Strategy Officer by InflaRx NV.
He received his undergraduate degree from Florida Atlantic University, a graduate degree from Florida Atlantic University and an MBA from the University of San Francisco.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PALISADE BIO, INC. 0,2 % | 10/06/2026 | 336.904 ( 0,2 % ) | 454 820 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| THERATECHNOLOGIES INC. | Director/Miembro de la Junta | 21/03/2024 |
| PALISADE BIO, INC. | Director/Miembro de la Junta | 10/06/2026 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Inversor de Capital Privado | 01/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| AMARIN CORPORATION PLC | Corporate Officer/Principal | 01/01/2023 |
| INFLARX N.V. | Corporate Officer/Principal | 29/06/2022 |
| SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | 01/01/2020 |
Raymond James & Associates, Inc.
Raymond James & Associates, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/01/2009 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Amarin Corp. Plc
Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for the prevention and treatment of gastrointestinal diseases & disorders | Health Technology |
Raymond James & Associates, Inc.
Raymond James & Associates, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Theratechnologies, Inc.
Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Florida Atlantic University
Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Francisco
University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InflaRx NV
InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.